The First Case of COVID-19 Reinfection in Duhok City, Kurdistan Region of Iraq: A Case Report

Abstract

Introduction: Coronavirus disease (COVID-19) causes a severe acute respiratory syndrome and is known as coronavirus 2 (SARS-CoV-2), which was first discovered in December, 2019 in Wuhan, China. The question of whether the COVID-19 patients that recover from the disease acquire immunity or are still susceptible to reinfection remains unanswered. Case Presentation: In this study, we presented the case of a 46-year-old male who recovered from the first round of COVID-19 infection. After symptom resolution, two consecutives negative real-time reverse transcription-polymerase chain reaction (RT-PCR) tests confirmed the negativity of the patient. Seven weeks after the first infection, the patient presented with fever and dry cough, and the infection was confirmed using real-time RT-PCR. The reinfection was associated with more severe symptoms, which required antiviral treatment. Conclusions: Our study indicated the possibility of COVID-19 reinfection. If the occurrence of reinfections is confirmed, it may implicate changes in the vaccine and community-based disease prevention strategies. Further studies are required to confirm the possibility of COVID-19 reinfection.

What might COVID-19 Patients Experience after Recovery? A Systematic Review

“…The screening of 204 studies revealed that only 13 case reports from 9 countries studied COVID-19 reinfection [80][81][82][83][84][85][86][87][88][89][90][91][92] . Most of the reported cases included patients presented with typical COVID-19 symptoms at the time of reinfection.…”

“…Most of the reported cases included patients presented with typical COVID-19 symptoms at the time of reinfection. At reinfection time, eight patients presented with mild COVID-19 symptoms 81,83,84,86,[88][89][90] , two patients presented with moderate COVID-19 symptoms 85,91 , and four patients with severe COVID-19 symptoms 80,82,87,89 . However, one patient was asymptomatic at the time of the supposed reinfection 92 .…”

A study of relationship between SARS-CoV-2 antibodies levels and host factors among general population in Zakho City, Iraq

“…1 The common clinical symptoms of the infection are fever, cough, shortness of breath, diarrheal, fatigue and myalgia. [2][3][4][5][6] The infection may cause a clinical syndrome that may include pneumonia, respiratory failure, thromboembolic phenomena and eventually death in severe cases. 7 In February 2020, the first cases of COVID-19 infection were reported in Kurdistan Region, Northern Iraq.…”

A rare case of absolute thrombocytopaenia in a COVID-19 patient: Case report

“…The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, which is responsible for coronavirus disease (COVID-19), is a serious public health concern worldwide with variable clinical manifestations [2–5][ [2] , [3] , [4] , [5] ]. In the Kurdistan region of Iraq, we experienced three waves with devastating impacts on our health system [ 6 , 7 ].…”